Omalizumab effective in treating inadequately controlled allergic asthma – BCM News

Omalizumab effective in treating inadequately controlled allergic asthma
BCM News
HOUSTON — (May 5, 2011) — Patients with severe allergic asthma that is inadequately controlled with the standard of care had improved symptoms and decreased flare-ups with injections of an antibody drug called omalizumab, according to experts at
Adding Omalizumab May Improve Uncontrolled AsthmaDoctors Lounge

all 3 news articles »

View full post on asthma – Google News

Smoke from controlled burns causing allergy and asthma symptoms for some – Kansas CW

Smoke from controlled burns causing allergy and asthma symptoms for some
Kansas CW
By Dave Roberts KWCH 12 Eyewitness News Many people in Sedgwick County say the smoke from controlled burns is causing them to have allergy and asthma symptoms. "The last few days, we've all had itchy noses, kind of runny noses, itchy eyes," said Isaac

and more »

View full post on asthma – Google News

Canadian asthmatics think disease controlled despite episodes – DigitalJournal.com

Canadian asthmatics think disease controlled despite episodes
DigitalJournal.com
The survey, Asthma Insight and Management in Europe and Canada (EUCAN AIM), found that 61 respondents said that they or their children had episodes within
CANADIANS WITH ASTHMA CONSIDER THEIR DISEASE 'WELL CONTROLLED' DESPITE SEVERE Canada NewsWire (press release)

all 6 news articles »

View full post on asthma – Google News

A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Placebo;   Drug: Tiotropium 5 µg q.d.;   Drug: Tiotropium 2.5 µg b.i.d.
Sponsors:   Boehringer Ingelheim Pharmaceuticals;   Pfizer
Recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days